Serono And RJL Systems Plead Guilty To AIDS Drug And Device Fraud
This article was originally published in The Gray Sheet
Executive Summary
Serono Labs will plead guilty to criminal charges that it offered kickbacks to doctors and conspired with medical device maker RJL Sciences to market an unapproved diagnostic device in order to increase sales of its drug Serostim, used to treat AIDS wasting
You may also be interested in...
Bioject Could Fold In June Without Additional Financing
Needle-free drug-delivery systems manufacturer Bioject announced April 7 that it may not be able to continue operations past May 31, despite its best efforts to stay afloat
Bioject Could Fold In June Without Additional Financing
Needle-free drug-delivery systems manufacturer Bioject announced April 7 that it may not be able to continue operations past May 31, despite its best efforts to stay afloat
Off-Label Promotion Not Enough For Fed Intervention – Patton Boggs Lawyer
Promotion of off-label applications alone will rarely trigger a U.S. Department of Justice investigation of a drug or device manufacturer, according to Patton Boggs partner Laura Laemmle